|
C5ORF34 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.145600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.399390E-01 |
| Normal-vs-Stage2 |
8.715400E-01 |
| Normal-vs-Stage3 |
5.195000E-01 |
| Normal-vs-Stage4 |
5.767600E-01 |
| Stage1-vs-Stage2 |
1.354620E-01 |
| Stage1-vs-Stage3 |
4.636000E-01 |
| Stage1-vs-Stage4 |
7.601800E-02 |
| Stage2-vs-Stage3 |
5.939200E-01 |
| Stage2-vs-Stage4 |
4.747800E-01 |
| Stage3-vs-Stage4 |
2.588200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.724000E-01 |
| Normal-vs-AfricanAmerican |
2.609800E-01 |
| Normal-vs-Asian |
4.151800E-01 |
| Caucasian-vs-AfricanAmerican |
4.816200E-01 |
| Caucasian-vs-Asian |
2.785600E-01 |
| AfricanAmerican-vs-Asian |
1.460170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.864200E-01 |
| Normal-vs-Female |
5.580300E-02 |
| Male-vs-Female |
4.360800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.637800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.018800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.201000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.899780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.375200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.781600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.404030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.054200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.376200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.726400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.385800E-01 |
| Normal-vs-Grade 2 |
3.642200E-01 |
| Normal-vs-Grade 3 |
2.126000E-01 |
| Normal-vs-Grade 4 |
5.389600E-01 |
| Grade 1-vs-Grade 2 |
3.042600E-01 |
| Grade 1-vs-Grade 3 |
5.134400E-01 |
| Grade 1-vs-Grade 4 |
1.079150E-01 |
| Grade 2-vs-Grade 3 |
5.627400E-01 |
| Grade 2-vs-Grade 4 |
1.820580E-01 |
| Grade 3-vs-Grade 4 |
1.204980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.707700E-02 |
| Normal-vs-ccB subtype |
6.349400E-01 |
| ccA subtype-vs-ccB subtype |
4.460100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.883200E-01 |
| Normal-vs-N1 |
4.522200E-01 |
| N0-vs-N1 |
4.158400E-01 |
|
|
